Virovek is a leading biotechnology company based in Hayward, CA, specializing in the production and development of custom adeno-associated virus (AAV) vectors for gene therapy research. With their patented BAC-TO-AAV technology, they are able to generate over 1E 16vg of AAV in a single run, making them the world's most efficient large-scale AAV manufacturing system.
In addition to AAV vectors, Virovek also offers a wide range of services and products including custom lentivirus and adenovirus packaging, gene cloning, quality control assays, and the production of plasmid DNA and recombinant baculovirus. With a commitment to precision and adherence to FDA's GLP principles, Virovek provides high-quality solutions for researchers in the field of gene therapy.
Generated from the website